Amisulpride Orally Disintegrating Tablets(Shanghai Zezheng Bio-pharma)

氨磺必利口崩片（上海则正医药）

Report date: 2026/03/31 20:00:21

Base Information

Drug NameAmisulpride Orally Disintegrating Tablets(Shanghai Zezheng Bio-pharma)
Drug Alias Name氨磺必利口崩片（2.2类改良型）HQ-0124HQ0124
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonistsDopamine D3 receptor antagonists
TargetsDopamine D2 receptorDopamine D3 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsSchizophrenia
Approved Indications in ChinaSchizophrenia
Original Approved Country/TerritoryMainland China
Original Approved Date2025/06/30
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Zezheng Bio-pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Zezheng Bio-pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSchizophrenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A